Cross‐sectional study on stigma and motivation to adhere to lifestyle modification among vulnerable populations with fatty liver disease
Open Access
- 21 June 2023
- journal article
- research article
- Published by Wiley in Obesity Science & Practice
- Vol. 9 (6) , 581-589
Abstract
Objectives: Adherence to lifestyle modification (diet, exercise, and alcohol cessation) for fatty liver disease (FLD) management remains challenging. The study examined stigma, barriers, and factors associated with motivation to adhere to lifestyle modification in a diverse and vulnerable population with FLD.Methods: From 2/19/2020 to 2/28/2022, 249 FLD patients within San Francisco safety‐net hepatology clinics were surveyed along with clinical data taken from medical records. Multivariable modeling assessed factors associated with motivation to adhere to lifestyle modification in a cross‐sectional study.Results: Median age was 53 years, 59% female, 59% Hispanic, 25% Asian/Pacific Islander, 9% White, and 2% Black, 79% were non‐English speakers, 64% had ≤ high school education, and 82% reported <$30,000 annual income. Common comorbidities included hyperlipidemia (47%), hypertension (42%), diabetes (39%), and heavy alcohol use (22%). Majority (78%) reported experiencing stigma, 41% reported extreme motivation, and 58% reported ≥ two barriers. When controlling for age, sex, Hispanic ethnicity, alcohol consumption, BMI, >high school (coef 1.41, 95% CI 0.34–2.48), stigma (coef 0.34, 95% CI 0.07–0.62), and depression (coef −1.52, 95% CI ‐2.79 to −0.26) were associated with motivation.Conclusions: Stigma is commonly reported among FLD patients. Interventions to enhance patient education and mental health support are critical to FLD management, especially in vulnerable populations.Keywords
Funding Information
- National Institutes of Health (K24AA022523, T32DK060414, U24MD017250)
This publication has 50 references indexed in Scilit:
- The 'donations for decreased ALT (D4D)' prosocial behavior incentive scheme for NAFLD patientsJournal of Public Health, 2013
- In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are notMetabolism, 2013
- Weight reduction for non-alcoholic fatty liver diseaseCochrane Database of Systematic Reviews, 2011
- Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 DiabetesDiabetes Care, 2010
- Bariatric surgery for non-alcoholic steatohepatitis in obese patientsCochrane Database of Systematic Reviews, 2010
- Integrating theory into community interventions to reduce liver cancer disparities: The Health Behavior FrameworkPreventive Medicine, 2010
- Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic SteatohepatitisHepatology, 2009
- Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced DiseaseGastroenterology, 2009
- Orlistat for overweight subjects with nonalcoholic steatohepatitisHepatology, 2009
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of EthnicityHepatology, 2004